![](/img/cover-not-exists.png)
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies
Gray, Heidi J., Bell-McGuinn, Katherine, Fleming, Gini F., Cristea, Mihaela, Xiong, Hao, Sullivan, Danielle, Luo, Yan, McKee, Mark D., Munasinghe, Wijith, Martin, Lainie P.Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.12.029
Date:
January, 2018
File:
PDF, 530 KB
english, 2018